Sildenafil Citrate Tablet
Product Images NDC 71205-721

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 71205-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-721-04 (Sildenafil Citrate 50 mg 30s)

Label for Sildenafil Tablets, USP 50 mg by Proficient Rx LP. The label shows a pack containing 4 film-coated caplet tablets. It includes storage instructions, a warning to keep out of reach of children, and manufacturer information for Umedica Laboratories Pvt. Ltd. The label displays NDC 71205-721-04 and barcode details.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

A line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers. The x-axis represents time post dose in hours, and the y-axis shows systolic blood pressure change in mmHg. Two lines compare Sildenafil 100 mg against placebo.*

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' shows changes in systolic blood pressure over an 8-hour period postdose. It compares two groups: Doxazosin plus Placebo (blue line) and Doxazosin plus Sildenafil 25 mg (black line), with blood pressure changes measured in mmHg on the vertical axis and time in hours on the horizontal axis.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

A line chart comparing mean standing systolic blood pressure changes from baseline over 8 hours post-dose between two treatments: Doxazosin plus Placebo (blue line) and Doxazosin plus Sildenafil 50 mg (black line). The y-axis shows change in mmHg, and the x-axis shows time in hours post-dose. Data points show trends of blood pressure changes for each treatment over time.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

A line graph depicting mean standing systolic blood pressure change from baseline over 8 hours after dosing. Two lines compare the effect of Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with placebo, showing blood pressure changes on the y-axis (mmHg) and time after dosing on the x-axis (hours).*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

A line graph titled 'Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers' showing plasma concentration (ng/mL) on the y-axis and time post dose (hours) on the x-axis. It compares the plasma concentration of sildenafil after administration of a generic treatment versus a commercial tablet, illustrating concentration peaks and decline over time.*

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

Two bar charts showing the effect of sildenafil citrate and placebo on maintenance of erection by baseline score. Each chart displays the percentage of patients at endpoint across baseline scores from 0 to 5, with bars representing different categories labeled 0 to 5.*

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

A bar graph comparing the percentage of patients reporting improvement across four treatment groups: Placebo, Sildenafil citrate 25 mg, Sildenafil citrate 50 mg, and Sildenafil citrate 100 mg. The y-axis shows percentage improvement from 0 to 100%, and the x-axis lists the treatment groups with patient counts. Improvement increases with higher Sildenafil citrate doses, from 24% in placebo to 82% at 100 mg.*

FDA Label Image

Sildenafil-citrate-strecture (Sildenafil Citrate Strecture)

Chemical structure of Sildenafil Citrate depicted with molecular groups and bonds, showing the detailed arrangement of atoms consistent with the compound's chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.